| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Avalo Therapeutics, Inc.
13G/A
AVTX · 05338F306
|
4.2% |
8/27/2025
Event 8/6/2025
|
||||
|
iBio, Inc.
13G/A
IBIO · 451033708
|
3.1% |
7/30/2025
Event 6/30/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.